Caxton Associates (New York)’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
Caxton Associates (New York)'s THC Position: Q4 2024 in Review
Caxton Associates (New York) reduced its Tenet Healthcare (THC) stake by 82% in Q4 2024, selling an estimated $2.06M and leaving 3,123 shares worth $394K. The position accounts for 0.01% of the portfolio, ranked #371.
Caxton Associates (New York) first reported a position in THC in Q3 2024 and has held it in 2 quarters since. The position peaked at $2.83M in Q3 2024. 577 funds tracked by Wall St. Rank hold THC as of Q4 2024.
- Caxton Associates (New York) held 3,123 shares of Tenet Healthcare worth $394K as of Q4 2024.
- Caxton Associates (New York) sold 13,882 Tenet Healthcare shares in Q4 2024, an estimated $2.06M.
- Tenet Healthcare made up 0.01% of Caxton Associates (New York)'s portfolio in Q4 2024, its #371 holding.
- Caxton Associates (New York) first reported a position in Tenet Healthcare in Q3 2024 and has held it in 2 quarters since.
- Caxton Associates (New York)'s Tenet Healthcare position peaked at $2.83M in Q3 2024.
- 577 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.